Stay updated on Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page.

Latest updates to the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 added and v3.4.1 removed from the version history; this is a minor update to the history list, and to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed; these are minor release-note updates to the site interface and do not alter study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary toggle and color-coded change highlights (green for additions, red for deletions). The revision label was updated to v3.4.0 and capitalization of the No FEAR Act data text was adjusted.SummaryDifference1%

- Check41 days agoChange DetectedRevision: v3.3.4 was added to the history and Revision: v3.3.3 was removed; this reflects a site maintenance release rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a new revision entry (Revision: v3.3.3) to the Record History. The HHS Vulnerability Disclosure footer was removed and the older Revision: v3.3.2 entry was deleted.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Record History now shows an added Revision: v3.3.2 and a removed Revision: v3.2.0 for the ClinicalTrials.gov record NCT04802876. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page.